With the increase of population aging, the number of Alzheimer's disease (AD) patients is
also increasing. According to current estimates, approximately 11% of people over 65 suffer …

Diseases of the central nervous system (CNS) are challenging to treat, mainly due to the
blood-brain barrier (BBB), which restricts drugs in circulation from entering target regions in …

Mental illnesses including anxiety disorders, autism spectrum disorder, post-traumatic stress
disorder, schizophrenia, depression, and others exact an immense toll on the healthcare …

Central nervous system (CNS) diseases such as Alzheimer's disease (AD), Parkinson's
disease (PD), glioblastoma (GBM), and peripheral nerve injury have been documented as …

The conventional therapeutic approaches to treat autoimmune diseases through
suppressing the immune system, such as steroidal and non-steroidal anti-inflammatory …

Therapeutic genome editing has the potential to cure diseases by directly correcting genetic
mutations in tissues and cells. Recent progress in the clustered regularly interspaced short …

Ischemic stroke is defined as an infarction in the brain, caused by impaired cerebral blood
supply, leading to local brain tissue ischemia, hypoxic necrosis, and corresponding …

Shuttling various bioactive substances across the blood–brain barrier (BBB) bidirectionally,
extracellular vesicles (EVs) have been opening new frontiers for the diagnosis and therapy …

Alzheimer's disease (AD) is one of the most prevalent neurodegenerative diseases and a
major contributor to dementia. Although the cause of this condition has been identified long …

The prevalence of neurodegenerative, cerebrovascular, and psychiatric diseases and other
neurological disorders has increased dramatically worldwide. Fucoxanthin is an algal …